While a substantial portion of pipeline assets are externally sourced, many Big Pharmas are tapping into incubators and ...

President Donald Trump said on Tuesday that the United States would initially place a "small tariff" on pharmaceutical ...

Pfizer (PFE), and Sanofi (SNY) drew increased attention on Tuesday as traders reacted to the U.S. government’s move to halt ...

Trump is pushing drug companies to lower their prices, but experts cast doubt on how effective this endeavor will prove.

The decision comes after the department reviewed mRNA-related investments initiated during the COVID-19 pandemic, and includes the closure of 22 projects.

The Department of Health and Human Services (HHS) is winding down its mRNA vaccine development activities under the ...

US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...

One of Trump's demands was that the CEOs' companies limit drug costs for states' Medicaid plans to "most-favored nation" ...

We will be totally self-sufficient for the supply of medicines to American patients.” AstraZeneca CEO Pascal Soriot on the ...

Today’s Forbes CFO newsletter focuses on Aradhana Sarin’s journey from treating patients to becoming what she calls a ...

Antibody-drug conjugates are currently being investigated in more than 260 clinical trials.“It’s going to be the next novel ...

In an earnings call on July 29th, in which the company reported a 13% increase in half-year profits, he said about Britain ...